Crestone
About:
Crestone is a clinical stage biopharmaceutical company focused on inventing and developing novel mechanism.
Website: https://www.crestonepharma.com/
Top Investors: National Institute of Allergy and Infectious Diseases, Cystic Fibrosis Foundation
Description:
Crestone is a clinical-stage biopharmaceutical business that is developing novel medication candidates. The following are in the company's research pipeline: C. Treatments for C. diff, antibiotic-resistant Gram-positive infections, and tuberculosis.
Total Funding Amount:
$18.2M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Boulder, Colorado, United States
Founded Date:
2009-01-01
Founders:
John Rohloff, Nebojsa Janjic, Thale Jarvis, Urs Ochsner
Number of Employees:
11-50
Last Funding Date:
2020-07-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai